Technical Fact Sheet – Perchlorate November 2017
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sodium Perchlorate, Anhydrous
Sodium perchlorate, anhydrous sc-203398 Material Safety Data Sheet Hazard Alert Code Key: EXTREME HIGH MODERATE LOW Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME Sodium perchlorate, anhydrous STATEMENT OF HAZARDOUS NATURE CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO OSHA 29 CFR 1910.1200. NFPA FLAMMABILITY0 HEALTH2 HAZARD INSTABILITY2 OX SUPPLIER Santa Cruz Biotechnology, Inc. 2145 Delaware Avenue Santa Cruz, California 95060 800.457.3801 or 831.457.3800 EMERGENCY: ChemWatch Within the US & Canada: 877-715-9305 Outside the US & Canada: +800 2436 2255 (1-800-CHEMCALL) or call +613 9573 3112 SYNONYMS Cl-Na-O4, Na-Cl-O4, "perchloric acid, sodium salt", Irenat., anti-thyroid Section 2 - HAZARDS IDENTIFICATION CHEMWATCH HAZARD RATINGS Min Max Flammability: 0 Toxicity: 2 Body Contact: 2 Min/Nil=0 Low=1 Reactivity: 2 Moderate=2 High=3 Chronic: 2 Extreme=4 CANADIAN WHMIS SYMBOLS 1 of 8 EMERGENCY OVERVIEW RISK Explosive when mixed with combustible material. Harmful if swallowed. Irritating to eyes. POTENTIAL HEALTH EFFECTS ACUTE HEALTH EFFECTS SWALLOWED ! Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual. ! Symptoms of exposure to perchlorates include shortness of breath, difficulty breathing and a bluish discoloration of the skin. The effects may be delayed for several hours following exposure. <\p>. ! Nausea and vomiting are almost always apparent after chlorate poisonings usually with upper stomach pain. Diarrhea may also occur. <\p>. EYE ! This material can cause eye irritation and damage in some persons. SKIN ! There is some evidence to suggest that this material can cause inflammation of the skin on contact in some persons. -
Sodium Chloride (Halite, Common Salt Or Table Salt, Rock Salt)
71376, 71386 Sodium chloride (Halite, Common Salt or Table Salt, Rock Salt) CAS number: 7647-14-5 Product Description: Molecular formula: NaCl Appearance: white powder (crystalline) Molecular weight: 58.44 g/mol Density of large crystals: 2.17 g/ml1 Melting Point: 804°C1 Density: 1.186 g/ml (5 M in water)2 2 Solubility: 1 M in H2O, 20°C, complete, clear, colorless 2 pH: 5.0-8.0 (1 M in H2O, 25°C) Store at room temperature Sodium chloride is geologically stable. If kept dry, it will remain a free-flowing solid for years. Traces of magnesium or calcium chloride in commercial sodium chloride adsorb moisture, making it cake. The trace moisture does not harm the material chemically in any way. 71378 BioUltra 71386 BioUltra for molecular biology, 5 M Solution The products are suitable for different applications like purification, precipitation, crystallisation and other applications which require tight control of elemental content. Trace elemental analyses have been performed for all qualities. The molecular biology quality is also tested for absence of nucleases. The Certificate of Analysis provides lot-specific results. Much of the sodium chloride is mined from salts deposited from evaporation of brine of ancient oceans, or recovered from sea water by solar evaporation. Due to the presence of trace hygroscopic minerals, food-grade salt has a small amount of silicate added to prevent caking; as a result, concentrated solutions of "table salt" are usually slightly cloudy in appearance. 71376 and 71386 do not contain any anti-caking agent. Applications: Sodium chloride is a commonly used chemical found in nature and in all body tissue, and is considered an essential nutrient. -
Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility Through Gene-Environment Interactions
toxics Review Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility through Gene-Environment Interactions Dylan J. Wallis 1 , Lisa Truong 2 , Jane La Du 2, Robyn L. Tanguay 2 and David M. Reif 1,* 1 Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA; [email protected] 2 Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA; [email protected] (L.T.); [email protected] (J.L.D.); [email protected] (R.L.T.) * Correspondence: [email protected] Abstract: Exposure to endocrine-disrupting chemicals (EDCs) is linked to myriad disorders, charac- terized by the disruption of the complex endocrine signaling pathways that govern development, physiology, and even behavior across the entire body. The mechanisms of endocrine disruption in- volve a complex system of pathways that communicate across the body to stimulate specific receptors that bind DNA and regulate the expression of a suite of genes. These mechanisms, including gene regulation, DNA binding, and protein binding, can be tied to differences in individual susceptibility across a genetically diverse population. In this review, we posit that EDCs causing such differential responses may be identified by looking for a signal of population variability after exposure. We begin Citation: Wallis, D.J.; Truong, L.; La by summarizing how the biology of EDCs has implications for genetically diverse populations. We Du, J.; Tanguay, R.L.; Reif, D.M. then describe how gene-environment interactions (GxE) across the complex pathways of endocrine Uncovering Evidence for Endocrine- signaling could lead to differences in susceptibility. We survey examples in the literature of individual Disrupting Chemicals That Elicit susceptibility differences to EDCs, pointing to a need for research in this area, especially regarding Differential Susceptibility through the exceedingly complex thyroid pathway. -
Calcium Chloride CAS N°:10043-52-4
OECD SIDS CALCIUM CHLORIDE FOREWORD INTRODUCTION Calcium chloride CAS N°:10043-52-4 UNEP PUBLICATIONS 1 OECD SIDS CALCIUM CHLORIDE SIDS Initial Assessment Report For SIAM 15 Boston, USA 22-25th October 2002 1. Chemical Name: Calcium chloride 2. CAS Number: 10043-52-4 3. Sponsor Country: Japan National SIDS Contact Point in Sponsor Country: Mr. Yasuhisa Kawamura Director Second Organization Div. Ministry of Foreign Affairs 2-2-1 Kasumigaseki, Chiyoda-ku Tokyo 100 4. Shared Partnership with: 5. Roles/Responsibilities of the Partners: • Name of industry sponsor Tokuyama Corporation /consortium Mr. Shigeru Moriyama, E-mail: [email protected] Mr. Norikazu Hattori, E-mail: [email protected] • Process used 6. Sponsorship History • How was the chemical or This substance is sponsored by Japan under ICCA Initiative and category brought into the is submitted for first discussion at SIAM 15. OECD HPV Chemicals Programme ? 7. Review Process Prior to The industry consortium collected new data and prepared the the SIAM: updated IUCLID, and draft versions of the SIAR and SIAP. Japanese government peer-reviewed the documents, audited selected studies. 8. Quality check process: 9. Date of Submission: 10. Date of last Update: 2 UNEP PUBLICATIONS OECD SIDS CALCIUM CHLORIDE 11. Comments: No testing (X) Testing ( ) The CaCl2-HPV Consortium members: (Japan) Asahi Glass Co., Ltd. Central Glass Co., Ltd. Sanuki Kasei Co., Ltd. Tokuyama Corporation [a global leader of the CaCl2-HPV Consortium] Tosoh Corporation (Europe) Brunner Mond (UK) Ltd. Solvay S.A. (North America) The Dow Chemical Company General Chemical Industrial Products Inc. Tetra Technologies, Inc. -
Liothyronine Sodium(BANM, Rinnm) Potassium Perchlorate
2174 Thyroid and Antithyroid Drugs with methodological limitations. However, a controlled trial of In myxoedema coma liothyronine sodium may be liothyronine with paroxetine could not confirm any advantage of given intravenously in a dose of 5 to 20 micrograms by 3 O additive therapy. slow intravenous injection, repeated as necessary, usu- 1. Aronson R, et al. Triiodothyronine augmentation in the treat- HO I ally at intervals of 12 hours; the minimum interval be- ment of refractory depression: a meta-analysis. Arch Gen Psychi- OH atry 1996; 53: 842–8. tween doses is 4 hours. An alternative regimen advo- 2. Altshuler LL, et al. Does thyroid supplementation accelerate tri- NH2 cates an initial dose of 50 micrograms intravenously cyclic antidepressant response? A review and meta-analysis of I O the literature. Am J Psychiatry 2001; 158: 1617–22. followed by further injections of 25 micrograms every 3. Appelhof BC, et al. Triiodothyronine addition to paroxetine in I 8 hours until improvement occurs; the dosage may the treatment of major depressive disorder. J Clin Endocrinol then be reduced to 25 micrograms intravenously twice Metab 2004; 89: 6271–6. (liothyronine) daily. Obesity. Thyroid drugs have been tried in the treatment of obes- Liothyronine has also been given in the diagnosis of ity (p.2149) in euthyroid patients, but they produce only tempo- NOTE. The abbreviation T3 is often used for endogenous tri-io- hyperthyroidism in adults. Failure to suppress the up- rary weight loss, mainly of lean body-mass, and can produce se- dothyronine in medical and biochemical reports. Liotrix is USAN rious adverse effects, especially cardiac complications.1 for a mixture of liothyronine sodium with levothyroxine sodium. -
Package Insert TECHNETIUM Tc99m GENERATOR for the Production of Sodium Pertechnetate Tc99m Injection Diagnostic Radiopharmaceuti
NDA 17693/S-025 Page 3 Package Insert TECHNETIUM Tc99m GENERATOR For the Production of Sodium Pertechnetate Tc99m Injection Diagnostic Radiopharmaceutical For intravenous use only Rx ONLY DESCRIPTION The technetium Tc99m generator is prepared with fission-produced molybdenum Mo99 adsorbed on alumina in a lead-shielded column and provides a means for obtaining sterile pyrogen-free solutions of sodium pertechnetate Tc99m injection in sodium chloride. The eluate should be crystal clear. With a pH of 4.5-7.5, hydrochloric acid and/or sodium hydroxide may have been used for Mo99 solution pH adjustment. Over the life of the generator, each elution will provide a yield of > 80% of the theoretical amount of technetium Tc99m available from the molybdenum Mo99 on the generator column. Each eluate of the generator should not contain more than 0.0056 MBq (0.15 µCi) of molybdenum Mo99 per 37 MBq, (1 mCi) of technetium Tc99m per administered dose at the time of administration, and not more than 10 µg of aluminum per mL of the generator eluate, both of which must be determined by the user before administration. Since the eluate does not contain an antimicrobial agent, it should not be used after twelve hours from the time of generator elution. PHYSICAL CHARACTERISTICS Technetium Tc99m decays by an isomeric transition with a physical half-life of 6.02 hours. The principal photon that is useful for detection and imaging studies is listed in Table 1. Table 1. Principal Radiation Emission Data1 Radiation Mean %/Disintegration Mean Energy (keV) Gamma-2 89.07 140.5 1Kocher, David C., “Radioactive Decay Data Tables,” DOE/TIC-11026, p. -
Sodium Chlorate Process Liquor De-Chromed SN
SAFETY DATA SHEET This SDS adheres to the standards and regulatory requirements of the United States and may not meet the regulatory requirements in other countries. 1. Identification Product identifier Sodium Chlorate Process Liquor De-chromed SN Other means of identification De-chromed blend of Crystallizer Feed Liquor and Mother Liquor, NaClO3 Recommended use For internal transfer between ERCO Worldwide sodium chlorate manufacturing facilities for process purposes Recommended restrictions None known Manufacturer/Importer/Supplier/Distributor information Manufacturer Company name ERCO Worldwide Address 335 Carlingview Drive Unit 1 Etobicoke, M9W 5G8 Canada Telephone Information #: (416) 239-7111 (M- F: 8:00 am – 5:00pm EST) Website http://www.ercoworldwide.com E-mail [email protected] Emergency phone number Canada & USA: 1-800-424-9300 (CHEMTREC) Supplier Refer to Manufacturer 2. Hazard(s) Identification Physical hazards Oxidizing liquids Category 2 Health hazards Acute toxicity, oral Category 4 Environmental hazards Not currently regulated by OSHA, refer to Section 12 for additional information. OSHA defined hazards This mixture does not meet the classification criteria according to OSHA HazCom 2012. Label elements Signal word Danger Hazard statement May intensify fire; oxidizer. Harmful if swallowed. Page 1 of 15 Issue Date: 11/18/2020 Sodium Chlorate Process Liquor De-chromed SN Precautionary statement Prevention Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Keep away from clothing and other combustible materials. Wear protective gloves, protective clothing, eye protection, face protection. Response IF ON SKIN: Wash with plenty of water. Take off contaminated clothing and wash it before reuse. In case of fire: Use water to extinguish. -
Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment
EPA/635/R-20/239 IRIS Assessment Protocol www.epa.gov/iris Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment CASRN 7487-94-7 (Mercuric Chloride) CASRN 1344-48-5 (Mercuric Sulfide) CASRN 10112-91-1 (Mercurous Chloride) February 2021 Integrated Risk Information System Center for Public Health and Environmental Assessment Office of Research and Development U.S. Environmental Protection Agency Washington, DC Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment DISCLAIMER This document is a preliminary draft for review purposes only. This information is distributed solely for review purposes under applicable information quality guidelines. It has not been formally disseminated by the Environmental Protection Agency. It does not represent and should not be construed to represent any Agency determination or policy. It is being circulated for comments on its technical clarity and science policy implications. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. This document is a draft for review purposes only and does not constitute Agency policy. ii DRAFT―DO NOT CITE OR QUOTE Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment CONTENTS AUTHORS|CONTRIBUTORS|REVIEWERS ........................................................................................................ 1. INTRODUCTION ...................................................................................................................................... 1 1.1. -
Chloride Ions As Integral Parts of Hydrogen Bonded Networks in Aqueous Salt Solutions: the Appearance of Solvent Separated Anion Pairs†
Chloride ions as integral parts of hydrogen bonded networks in aqueous salt solutions: the appearance of solvent separated anion pairs† Ildikó Pethes*,a, Imre Bakób, László Pusztaia,c aWigner Research Centre for Physics, Konkoly Thege út 29-33., H-1121 Budapest, Hungary bResearch Centre for Natural Sciences, Magyar tudósok körútja 2, H-1117 Budapest, Hungary cInternational Research Organisation for Advanced Science and Technology (IROAST), Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan Abstract Hydrogen bonding to chloride ions has been frequently discussed over the past 5 decades. Still, the possible role of such secondary intermolecular bonding interactions in hydrogen bonded networks has not been investigated in any detail. Here we consider computer models of concentrated aqueous LiCl solutions and compute usual hydrogen bond network characteristics, such as distributions of cluster sizes and of cyclic entities, both for models that take and do not take chloride ions into account. During the analysis of hydrogen bonded rings, a significant amount of ‘solvent separated anion pairs’ have been detected at high LiCl concentrations. It is demonstrated that taking halide anions into account as organic constituents of the hydrogen bonded network does make the interpretation of structural details significantly more meaningful than when considering water molecules only. Finally, we compare simulated structures generated by ‘good’ and ‘bad’ potential sets on the basis of the tools * Corresponding author: e-mail: [email protected] †Electronic supplementary information (ESI) available. See DOI: … 1 developed here, and show that this novel concept is, indeed, also helpful for distinguishing between reasonable and meaningless structural models. -
0.9% Sodium Chloride Injection, USP Visiv
SODIUM CHLORIDE- sodium chloride injection, solution ICU Medical, Inc. ---------- 0.9% Sodium Chloride Injection, USP VisIV ™ Container Rx only DESCRIPTION 0.9% Sodium Chloride Injection, USP is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. Each 100 mL of 0.9% Sodium Chloride Injection, USP contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium (Na+) 154 mEq; chloride (Cl−) 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for the 100 mL and smaller containers is 6.0; for the 250 mL, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. This solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required, the unused portion should be discarded. 0.9% Sodium Chloride Injection, USP is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a clear multilayer polyolefin plastic film. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period. CLINICAL PHARMACOLOGY When administered intravenously, these solutions provide a source of water and electrolytes. Solutions which provide combinations of hypotonic or isotonic concentrations of sodium chloride are suitable for parenteral maintenance or replacement of water and electrolyte requirements. -
Sodium Hypochlorite Stability
SODIUM HYPOCHLORITE STABILITY Sodium hypochlorite is an excellent sanitiser that is commonly used in industries world-wide. Its’ popularity is derived from the fact that while it has a proven wide-spectrum of activity, it deodorises, it is non- poisonous in low concentrations and it breaks down to give harmless naturally occurring products (salt, water, oxygen). While sodium hypochlorite has many positive aspects it is a reactive compound that degrades over time. The decomposition reaction is as follows: 2 NaOCl → 2NaCl + O2 Sodium Sodium Oxygen Hypochlorite Chloride The stability and shelf life of commercially available sodium hypochlorite is adversely affected by the following factors: • Heat - For example: the shelf life of 12.5% sodium hypochlorite is decreased by a factor of approximately three times when the storage temperature is raised from 25°C to 35°C. • Low pH - Lowering the pH will decrease the sodium hypochlorite in solution, and can liberate free chlorine. • Sunlight - Exposure to UV light degrades sodium hypochlorite. • Contamination - The presence of certain metals in solution (eg nickel) will promote degradation. Some metals (e.g. iron) are not particularly detrimental to the stability. Standards Australia has recognised the stability issues associated with sodium hypochlorite. In AS1087- 1991 (“Sodium hypochlorite solutions for use in the dairying industry”, which is the most relevant standard available) the standard states: 1) “When solutions of sodium hypochlorite are allowed to stand, the amount of available chlorine slowly diminishes” and 2) “Two consequences of this decomposition are that first, the chemical properties specified must be determined, and the product delivered to the customer without undue delay; and second, the concentration of the sanitising solution must be checked before use and, if necessary, allowance made when sanitising if the solution is under-strength.” AS1087-1991 sets a few minimum requirements for stability of 12.5% sodium hypochlorite: • The initial product must have a level of 125– 135 g/L available chlorine. -
Chemical Specific Parameters May 2019
Regional Screening Level (RSL) Chemical-specific Parameters Supporting Table April 2019 Contaminant Molecular Weight Volatility Parameters Melting Point Density Diffusivity in Air and Water Partition Coefficients Water Solubility Tapwater Dermal Parameters H` HLC H` and HLC VP VP MP MP Density Density Dia Diw Dia and Diw Kd Kd Koc Koc log Kow log Kow S S B τevent t* Kp Kp Analyte CAS No. MW MW Ref (unitless) (atm-m3/mole) Ref mmHg Ref C Ref (g/cm3) Ref (cm2/s) (cm2/s) Ref (L/kg) Ref (L/kg) Ref (unitless) Ref (mg/L) Ref (unitless) (hr/event) (hr) (cm/hr) Ref Acephate 30560-19-1 1.8E+02 PHYSPROP 2.0E-11 5.0E-13 EPI 1.7E-06 PHYSPROP 8.8E+01 PHYSPROP 1.4E+00 CRC89 3.7E-02 8.0E-06 WATER9 (U.S. EPA, 2001) 1.0E+01 EPI -8.5E-01 PHYSPROP 8.2E+05 PHYSPROP 2.1E-04 1.1E+00 2.7E+00 4.0E-05 EPI Acetaldehyde 75-07-0 4.4E+01 PHYSPROP 2.7E-03 6.7E-05 PHYSPROP 9.0E+02 PHYSPROP -1.2E+02 PHYSPROP 7.8E-01 CRC89 1.3E-01 1.4E-05 WATER9 (U.S. EPA, 2001) 1.0E+00 EPI -3.4E-01 PHYSPROP 1.0E+06 PHYSPROP 1.3E-03 1.9E-01 4.5E-01 5.3E-04 EPI Acetochlor 34256-82-1 2.7E+02 PHYSPROP 9.1E-07 2.2E-08 PHYSPROP 2.8E-05 PHYSPROP 1.1E+01 PubChem 1.1E+00 PubChem 2.2E-02 5.6E-06 WATER9 (U.S.